Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accu…
Vital today announces its partnership with Children’s Hospital Los Angeles (CHLA), introducing an AI-powered patient experience app that provides more clarity and transparency to patients and families in the emergency department.
Software Advice’s Online Pharmacy Survey reveals that patients who rated pharmacy apps as very easy to use dropped from 69% in 2022 to 46% in 2024.AUSTIN, Texas--(BUSINESS WIRE)--With an overwhelming majority of patients turning to digital platforms f...
Aptar has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and ra…
Healthcare providers and insurers look to digital records and tools to boost quality and efficiency, with GenAI emerging as next major trend, ISG Provider Lens™ report saysSTAMFORD, Conn.--(BUSINESS WIRE)--$III #DigitalHealthcare--Healthcare companies...
Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, today announced that they have been chosen by the United States Department of Defense (DoD) Defense Health Agency’s Posttraumatic Stress Disorder Drug Treatment Program as a technology partner for a clinical study aimed at developing new therapies to treat PTSD.
The University of Rochester Medical Center today announced a first-of-its-kind initiative to improve health care access and wellness outcomes in rural communities in Upstate New York through the distribution of telehealth stations conveniently located at local bank branches.
Program drives increased education and access to high-quality testing for early detection to protect kidney health and lower healthcare costsAUSTIN, Texas--(BUSINESS WIRE)--Everly Health, a leading remote-based healthcare company expanding access to v...
Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care.
Data from the first US comprehensive single center experience at St Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session at the AF Symposium 2024 in Boston, shows that Left Atrial Appendage Occlusion (LAAO) procedures planned by means of FEops HEARTguideTM result in significantly improved procedural efficiency.